P2.15-29 Eligibility for Anti-Angiogenic Treatments in Patients With Squamous Non-Small Cell Lung Cancer (SQ-NSCLC): EPISQUAMAB Study (GFPC 2015-01)

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1471
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Potential Antiangiogenic Treatment Eligibility of Patients With Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)

Cancer Management and Research
Oncology
2019English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine
2018English

P2.04-29 Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Newly Developed Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

P2.15-16 Clinical Economic Impact of Improved Genotyping in Patients With Advanced Non-Small Cell Lung Adenocarcinoma (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Effectiveness of First-Line Treatments in Metastatic Squamous Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2019English

P3.17-01 PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients From Brazil

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pcn102 - Extra-Cost of Brain Metastases in Patients With Non-Squamous Non-Small Cell Lung Cancer (Nsclc) : A French National Hospital Database Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy